EXCELYA/XENOTHERA
3.5.2021 12:15:09 CEST | Business Wire | Press release
The biotech company XENOTHERA has begun the European clinical trial of its anti-COVID treatment, XAV-19. The Nantes laboratory is the sponsor of the trial, called EUROXAV, which will be carried out by Excelya , a leading European contract research organization (CRO) specializing in clinical research. EUROXAV is a multi-center, double-blind phase III trial that will recruit 722 patients with moderate COVID, hospitalized or monitored remotely. The trial will take place in Greece, Bulgaria, Romania, Spain and Turkey.
The first patient in the trial was recruited on April 28th at Professor Poulakou's center (GR04) in Greece. The cohort of 722 patients will complement the 398 patients in the POLYCOR trial, a trial carried out in 35 French hospitals under the sponsorship of the Nantes University Hospital, which has just closed its recruitment phase with results expected Summer 2021.
"Excelya is very proud to support XENOTHERA in the development of XAV19, which holds great promise in the battle against COVID19. After taking several months to develop the EUROXAV project, the inclusion of this first patient represents an important milestone. We hope to work quickly to make results available and initiate the next steps to benefit patients and caregivers," said Alan Morgan, CEO of Excelya .
“This milestone marks the start of the EUROXAV trial, the results of which are awaited with great interest. The aim of the trial is to evaluate the efficacy of XAV-19 in hospitalized and ambulatory patients, which will allow us to analyze the medical value of XAV-19 in clinical situations where there is currently no satisfactory therapeutic solution.” comments Odile Duvaux, co-founder and president of XENOTHERA.
*********************
About XAV-19:
XENOTHERA's drug candidate XAV-19 is a protective anti-SARS-CoV-2 polyclonal antibody similar to the natural human response
. Based on a unique and patented proprietary technology, it acts through several mechanisms of action, including neutralizing the virus, reducing inflammation and limiting the risk of cytokine storms.
About XENOTHERA:
Founded in 2014, XENOTHERA is a Nantes-based biotech company that develops "glyco-humanized" polyclonal antibodies. Its technological platform is built on a dual expertise in genetics and immunology. The company has a complete portfolio of products, the first of which, LIS1, an immunosuppressant in transplantation, has been in the clinic since 2019. XENOTHERA has also been developing its treatment for coronavirus infections for several years. XAV-19 is XENOTHERA's treatment for patients at the beginning of hospitalization, it is based on a unique patented antibody production technology, developed and proven for several years by the biotech.
XENOTHERA, a member of the Atlanpole Biotherapies competitiveness cluster, is part of the scientific and medical environment of the Pays de la Loire. The company has been supported since its creation by private investors, by the Pays de la Loire Region and by BPI France. Since its creation, the company has raised more than 23 million euros to finance all of its products.
For more information: www.xenothera.com
Follow XENOTHERA on social networks: LinkedIn
Twitter
About Excelya Group:
Excelya is an independent European contract research organization with over 800 employees, 17 offices and 12 legal entities spread throughout Europe. Excelya offers all cooperation models, from consulting to functional service providing to full-service. It provides these research services across multiple industries, including pharmaceutical, biotech, medical devices, cosmetics and nutrition. As a fully integrated CRO, Excelya undertakes the design and execution of Phase I clinical trials to post-marketing studies, safety, biometrics and market access projects. Excelya is committed to providing preeminent experts who work hand-in-hand with its clients to accelerate end-to-end drug development, leverage data science and reimagine patient care.
For more information, please visit excelya.com
.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210503005365/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Türk Telekom and P.I. Works Announce Strategic Collaboration on AI-Driven 5G Network Slicing at MWC Barcelona3.3.2026 10:16:00 CET | Press release
Türk Telekom and P.I. Works today announced a strategic collaboration on AI-driven 5G network slicing assurance, unveiled during GSMA Mobile World Congress (MWC) Barcelona 2026. Türk Telekom has successfully trialed P.I. Works’ AI-powered 5G RAN Slice Assurance solution in Türk Telekom R&D Innovation & Test Center, strengthening its ability to deliver differentiated and performance-assured 5G services. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260303543772/en/ The solution is designed to ensure network slicing performance by enabling real-time monitoring of slice-level KPIs, early detection of performance degradations, and AI-assisted root cause analysis. With these capabilities, Türk Telekom aims to proactively manage service levels, and ensure consistent service continuity across different 5G slice types. Türk Telekom Ebubekir Şahin stated: “As we approach the 5G era, we continuously evolve our mobile network to deliv
BlackLine Brings BeyondTheBlack to Paris, Showcasing Innovation and Best Practice for Modern Finance Teams3.3.2026 10:00:00 CET | Press release
BlackLine, Inc. (Nasdaq: BL), the future-ready platform for the Office of the CFO, today announces BeyondTheBlack Paris, taking place on Thursday 25 June 2026 at 28 George V, Paris 8. BeyondTheBlack Paris will bring together finance and accounting leaders from across France and the wider EMEA region for a full day dedicated to finance transformation, industry best practice and peer-led learning. As part of BlackLine’s global BeyondTheBlack event series, the Paris event will focus on how finance teams can streamline operations, improve accuracy and unlock greater strategic value through automation and intelligence. The programme will feature keynote sessions from Owen Ryan, CEO of BlackLine, and Philippe Omer-Decugis, General Manager, EMEA, followed by a technology-focused session from Jeremy Ung, CTO, who will unveil exclusive major product announcements while examining the role of AI and innovation across finance and accounting. Attendees will also hear from partners and customers thr
BlackLine Announces BeyondTheBlack London, Bringing Finance Leaders Together to Shape the Future of the Office of the CFO3.3.2026 10:00:00 CET | Press release
BlackLine, Inc. (Nasdaq: BL), the future-ready platform for the Office of the CFO, today announces BeyondTheBlack London, taking place on Tuesday 14 April 2026 at the London Hilton on Park Lane. BeyondTheBlack is BlackLine’s award-winning event series, designed to bring finance and accounting leaders together to explore how modern teams can transform core financial processes, reduce manual work, and operate with greater accuracy, efficiency and intelligence. The London event will convene senior finance professionals, partners and BlackLine executives for a full day of learning, peer-led insight and networking. The agenda will open with plenary sessions from Owen Ryan, CEO of BlackLine, and Philippe Omer-Decugis, General Manager, EMEA, followed by a keynote from Jeremy Ung, CTO, who will share BlackLine’s latest thinking on AI, automation and innovation across the Office of the CFO. Morning sessions will also include an expert partner panel and guest keynote, before attendees move into
Smartstream’s Final ISO 20022 Paper Reveals 67% of Errors Are Due to Data Quality and Calls for a Holistic Operating Model3.3.2026 09:55:00 CET | Press release
Smartstream, the trusted data solutions provider for leading global financial institutions and enterprises, today announces a new paper which marks the conclusion of a four-part series in partnership with The ValueExchange - it examines the structural pressures reshaping the asset servicing industry. Titled ‘The Case for Transformation’, the report argues that incremental fixes are no longer sufficient, and that firms must pursue a holistic operating model change, with ISO 20022 and messaging interoperability at the core. Over the course of the series, the research has documented how asset servicing has reached a genuine inflection point. Transaction volumes are increasing at more than 25% year on year. Settlement and reporting timelines are shrinking. Regulatory expectations continue to intensify, with the mandatory transition to ISO 20022 by November 2026 representing a critical milestone. Yet many operating models remain rooted in outdated frameworks never designed for scale, transp
AppLogic Networks Completes Live Trial at JANOG57 in Osaka, Powering New AI-Driven Dashboards to Enhance NOC Team’s Capabilities3.3.2026 09:00:00 CET | Press release
AppLogic Networks today announced the results of a live trial deployment at JANOG57 in Osaka, where the JANOG Network Operations Center (“NOC”) team used AppLogic Networks data for real-time monitoring, troubleshooting, and experience reporting during the event. The trial showcased an Elevated Observability approach that goes beyond traditional monitoring by adding B.E.S.T. insights (Behavior, Experience, Sentiment, and Trends) that help teams make faster decisions, reduce guesswork, and support new services in high-demand environments. Hosted by SAKURA internet Inc., JANOG57 is one of Japan’s largest operator conferences that brings together thousands of attendees, dozens of sessions, and more than 100 booths. AppLogic Networks participated as an infrastructure supplier, supporting the NOC team alongside other technology vendors. AI-driven experience scoring powered by AppLogic Networks data During the event, the NOC team streamed AppLogic Networks data into Grafana and quickly built
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom